RWB
JNCE

RMR Wealth Builders’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

RMR Wealth Builders’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,000
Closed -$7K – 481
2020
Q2 		$7K Buy
+1,000
New +$5.39K 0.01% 365

Other funds holding JNCE

TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

RMR Wealth Builders's JNCE Position: Q3 2020 in Review

RMR Wealth Builders sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q3 2020, closing a stake of 1,000 shares — an estimated $7K sold.

RMR Wealth Builders first reported a position in JNCE in Q2 2020 and held it in 1 quarter. The position peaked at $7K in Q2 2020. 102 funds tracked by Wall St. Rank hold JNCE as of Q3 2020.

  • RMR Wealth Builders reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • RMR Wealth Builders sold 1,000 Jounce Therapeutics, Inc. Common Stock shares in Q3 2020, an estimated $7K.
  • RMR Wealth Builders first reported a position in Jounce Therapeutics, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • RMR Wealth Builders's Jounce Therapeutics, Inc. Common Stock position peaked at $7K in Q2 2020.
  • 102 funds tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q3 2020.

Based on RMR Wealth Builders's 13F filing for Q3 2020, filed 13 Nov 2020.